Modeling human influenza infection in the laboratory

References

• HamiltonBEMininoAMMartinJAKochanekKDStrobinoDMGuyerBAnnual summary of vital statistics: 2005Pediatrics2007119234536017272625
   PubMed Web of Science ®Google Scholar
• JohnsonNPMuellerJUpdating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemicBull Hist Med200276110511511875246
   PubMed Web of Science ®Google Scholar
• DushoffJPlotkinJBViboudCEarnDJSimonsenLMortality due to influenza in the United States – an annualized regression approach using multiple-cause mortality dataAm J Epidemiol2006163218118716319291
   PubMed Web of Science ®Google Scholar
• ThompsonWWShayDKWeintraubEInfluenza-associated hospitalizations in the United StatesJAMA2004292111333134015367555
   PubMed Web of Science ®Google Scholar
• JaggerBWWiseHMKashJCAn overlapping protein-coding region in influenza A virus segment 3 modulates the host responseScience2012337609119920422745253
   PubMed Web of Science ®Google Scholar
• GorbachSLBartlettJGBlacklowNRInfectious Diseases3rd edPhiladelphiaLippincott Williams & Wilkins2004
   Google Scholar
• WebsterRGKendalAPGerhardWAnalysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparationsVirology197996125826488798
   PubMed Web of Science ®Google Scholar
• WebsterRGWrightSMCastrucciMRBeanWJKawaokaYInfluenza – a model of an emerging virus diseaseIntervirology1993351–416258407243
   PubMed Web of Science ®Google Scholar
• MosconaANeuraminidase inhibitors for influenzaN Engl J Med2005353131363137316192481
   PubMed Web of Science ®Google Scholar
• SteinhauerDARole of hemagglutinin cleavage for the pathogenicity of influenza virusVirology1999258112010329563
   PubMed Web of Science ®Google Scholar
• GubarevaLVKaiserLHaydenFGInfluenza virus neuraminidase inhibitorsLancet2000355920682783510711940
   PubMed Web of Science ®Google Scholar
• ZuckermanAJPrinciples and Practice of Clinical Virology6th edChichester, UK/Hoboken, NJJohn Wiley & Sons2009
   Google Scholar
• SimonsenLThe global impact of influenza on morbidity and mortalityVaccine199917Suppl 1S3S1010471173
   PubMed Web of Science ®Google Scholar
• GilletYVanhemsPLinaGFactors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing panton-valentine leukocidinClin Infect Dis200745331532117599308
   PubMed Web of Science ®Google Scholar
• BridgesCBKuehnertMJHallCBTransmission of influenza: implications for control in health care settingsClin Infect Dis20033781094110114523774
   PubMed Web of Science ®Google Scholar
• GlezenWPClinical practice. Prevention and treatment of seasonal influenzaN Engl J Med2008359242579258519073977
   PubMed Web of Science ®Google Scholar
• FioreAEShayDKBroderKCenters for Disease Control and Prevention (CDC)Advisory Committee on Immunization Practices (ACIP)Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008MMWR Recomm Rep200857RR–716018685555
   PubMedGoogle Scholar
• HarperSABradleyJSEnglundJAExpert Panel of the Infectious Diseases Society of AmericaSeasonal influenza in adults and children – diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of AmericaClin Infect Dis20094881003103219281331
   PubMed Web of Science ®Google Scholar
• CDCUpdated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009–2010 SeasonAtlantaCDC2009
   Google Scholar
• WeinstockDMZuccottiGAdamantane resistance in influenza AJAMA2006295893493616493107
   PubMed Web of Science ®Google Scholar
• PalesePCompansRWInhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of actionJ Gen Virol1976331159163978183
   PubMed Web of Science ®Google Scholar
• HaydenFGOsterhausADTreanorJJEfficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study GroupN Engl J Med1997337138748809302301
   PubMed Web of Science ®Google Scholar
• JeffersonTJonesMDoshiPDel MarCNeuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisBMJ2009339b510619995812
   PubMed Web of Science ®Google Scholar
• McGeerAGreenKAPlevneshiAToronto Invasive Bacterial Diseases NetworkAntiviral therapy and outcomes of influenza requiring hospitalization in Ontario, CanadaClin Infect Dis200745121568157518190317
   PubMed Web of Science ®Google Scholar
• JainSKamimotoLBramleyAM2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation TeamHospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009N Engl J Med2009361201935194419815859
   PubMed Web of Science ®Google Scholar
• LeeNChanPKChoiKWFactors associated with early hospital discharge of adult influenza patientsAntivir Ther200712450150817668558
   PubMed Web of Science ®Google Scholar
• (US) CfDCaPInfluenza Antiviral Drug Resistance2015 Available from: http://www.cdc.gov/flu/about/qa/antiviralresistance.htmAccessed April 23, 2015
   Google Scholar
• de JongMDTranTTTruongHKOseltamivir resistance during treatment of influenza A (H5N1) infectionN Engl J Med2005353252667267216371632
   PubMed Web of Science ®Google Scholar
• LeQMKisoMSomeyaKAvian fu: isolation of drug-resistant H5N1 virusNature20054377062110816228009
   PubMed Web of Science ®Google Scholar
• StottDJKerrGCarmanWFNosocomial transmission of influenzaOccup Med2002525249253
   Google Scholar
• DowdleWRHattwickMASwine influenza virus infections in humansJ Infect Dis1977136SupplS386S389342616
   PubMed Web of Science ®Google Scholar
• HorcajadaJPPumarolaTMartinezJAA nosocomial outbreak of influenza during a period without influenza epidemic activityEur Respir J200321230330712608445
   PubMed Web of Science ®Google Scholar
• LipsitchMGalvaniAPEthical alternatives to experiments with novel potential pandemic pathogensPLoS Med2014115e100164624844931
   PubMed Web of Science ®Google Scholar
• KlotzLCSylvesterEJThe unacceptable risks of a man-made pandemicBull At Sci2012
   Google Scholar
• HenkelRMillerTWeyantRMonitoring select agent theft, loss and release reports in the United States–2004–2010Appl Biosaf201218171180
   Google Scholar
• Lloyd-SmithJOSchreiberSJKoppPEGetzWMSuperspreading and the effect of individual variation on disease emergenceNature2005438706635535916292310
   PubMed Web of Science ®Google Scholar
• ChosewoodLCWilsonDECenters for Disease Control and Prevention (US), National Institutes of Health (US)Biosafety in Microbiological and Biomedical Laboratories5th edWashington, DCUS Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health2009
   Google Scholar
• WebsterRGPeirisMChenHGuanYH5N1 outbreaks and enzootic influenzaEmerg Infect Dis20061213816494709
   PubMed Web of Science ®Google Scholar
• VirojWSwine Flu and Pig Borne DiseasesHauppauge, NYNova Science2009
   Google Scholar
• RobinsonJLLeeBEPatelJSwine influenza (H3N2) infection in a child and possible community transmission, CanadaEmerg Infect Dis200713121865187018258037
   PubMed Web of Science ®Google Scholar
• [No authors listed]A long pauseNat Med201319211323389588
   PubMed Web of Science ®Google Scholar
• WHOCumulative Number of Confrmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003–20152015 Available from: http://www.who.int/influenza/human_animal_interface/EN_GIP_20150106CumulativeNumberH5N1cases_corrected.pdf?ua=1Accessed February 13, 2015
   Google Scholar
• MurrayCJLopezADChinBFeehanDHillKHEstimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysisLancet200636895542211221817189032
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC)Department of Health and Human Services (HHS)Possession, use, and transfer of select agents and toxinsFed Regist201277194610836111523038847
   PubMedGoogle Scholar
• Centers for DiseaseCPrevention; GangadharanDSmithJWeyantRBiosafety recommendations for work with influenza viruses containing a hemagglutinin from the A/goose/Guangdong/1/96 LineageMMWR201362RR–0617
   Google Scholar
• SmorodintseffATushinskyMdrobyshevskayaAIKorovinAAOsetroffAIInvestigation on volunteers infected with the influenza virusAm J Med Sci19371942159170
   Google Scholar
• DawkinsATJrGallagerLRTogoYHornickRBHarrisBAStudies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochlorideJAMA196820313109510994870515
   PubMed Web of Science ®Google Scholar
• IsonMGCampbellVRemboldCDentJHaydenFGCardiac findings during uncomplicated acute influenza in ambulatory adultsClin Infect Dis200540341542215668866
   PubMed Web of Science ®Google Scholar
• Institute of Laboratory Animal Resources (US)Committee on Care and Use of Laboratory AnimalsGuide for the Care and Use of Laboratory AnimalsBethesda, MDUS Dept of Health and Human Services, Public Health Service, NIH Publication2011v
   Google Scholar
• ShopeREThe infection of ferrets with swine influenza virusJ Exp Med1934601496119870285
   PubMedGoogle Scholar
• GovorkovaEAIlyushinaNABoltzDADouglasAYilmazNWebsterRGEfficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virusAntimicrob Agents Chemother20075141414142417296744
   PubMed Web of Science ®Google Scholar
• BoltzDARehgJEMcClarenJWebsterRGGovorkovaEAOseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret modelJ Infect Dis200819791315132318422444
   PubMed Web of Science ®Google Scholar
• BodewesRKreijtzJHvan AmerongenGPathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculationAm J Pathol20111791303621640972
   PubMed Web of Science ®Google Scholar
• GambottoABarratt-BoyesSMde JongMDNeumannGKawaokaYHuman infection with highly pathogenic H5N1 influenza virusLancet200837196221464147518440429
   PubMed Web of Science ®Google Scholar
• JayaramanAChandrasekaranAViswanathanKRamanRFoxJGSasisekharanRDecoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tractPLoS One201272e2751722359533
   PubMed Web of Science ®Google Scholar
• NgPSBöhmRHartley-TassellLEFerrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptorsNat Commun20145575025517696
   PubMed Web of Science ®Google Scholar
• van RielDMunsterVJde WitEH5N1 virus attachment to lower respiratory tractScience2006312577239916556800
   PubMed Web of Science ®Google Scholar
• van RielDMunsterVJde WitEHuman and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammalsAm J Pathol200717141215122317717141
   PubMed Web of Science ®Google Scholar
• BouvierNMLowenACAnimal models for influenza virus pathogenesis and transmissionViruses2010281530156321442033
   PubMed Web of Science ®Google Scholar
• ZitzowLARoweTMorkenTShiehWJZakiSKatzJMPathogenesis of avian influenza A (H5N1) viruses in ferretsJ Virol20027694420442911932409
   PubMed Web of Science ®Google Scholar
• MatsuokaYLamirandeEWSubbaraoKThe ferret model for influenzaCurr Protoc Microbiol2009 Chapter 15:Unit15G.12
   Google Scholar
• MaherJADeStefanoJThe ferret: an animal model to study influenza virusLab Anim20043395053
   Web of Science ®Google Scholar
• PlourdeJRPylesJALaytonRCVaughanSETipperJLHarrodKSNeurovirulence of H5N1 infection in ferrets is mediated by multifocal replication in distinct permissive neuronal cell regionsPLoS One2012710e4660523056366
   PubMed Web of Science ®Google Scholar
• FrancisTMagillTPImmunological studies with the virus of influenzaJ Exp Med193562450551619870430
   PubMedGoogle Scholar
• HerlocherMLEliasSTrusconRFerrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virusJ Infect Dis2001184554254611494159
   PubMed Web of Science ®Google Scholar
• MainesTRChenLMMatsuokaYLack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret modelProc Natl Acad Sci U S A200610332121211212616880383
   PubMed Web of Science ®Google Scholar
• YunNELindeNSZacksMAInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Virology2008374119820918234269
   PubMed Web of Science ®Google Scholar
• MendelDBTaiCYEscarpePAOral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionAntimicrob Agents Chemother19984236406469517945
   PubMed Web of Science ®Google Scholar
• LiWEscarpePAEisenbergEJIdentification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071Antimicrob Agents Chemother19984236476539517946
   PubMed Web of Science ®Google Scholar
• CochranKWMaassabHFTsunodaABerlinBSStudies on the antiviral activity of amantadine hydrochlorideAnn N Y Acad Sci196513014324394285587
   PubMed Web of Science ®Google Scholar
• FentonRJBessellCSpillingCRPotterCWThe effects of peroral or local aerosol administration of 1-aminoadamantane hydrochloride (amantadine hydrochloride) on influenza infections of the ferretJ Antimicrob Chemother197735463472903327
   PubMed Web of Science ®Google Scholar
• StaeheliPHallerOBollWLindenmannJWeissmannCMx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virusCell19864411471583000619
   PubMed Web of Science ®Google Scholar
• GrimmDStaeheliPHufbauerMReplication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance geneProc Natl Acad Sci U S A2007104166806681117426143
   PubMed Web of Science ®Google Scholar
• YangYTEvansCAHypothermia in mice due to influenza virus infectionProc Soc Exp Biol Med196110877678014008977
   PubMed Web of Science ®Google Scholar
• RadiganKAUrichDMisharinAVThe effect of rosuvastatin in a murine model of influenza A infectionPLoS One201274e3578822536437
   PubMed Web of Science ®Google Scholar
• RadiganKAMorales-NebredaLSoberanesSImpaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophagesPLoS One201499e10813825232724
   PubMed Web of Science ®Google Scholar
• Morales-NebredaLChiMLecuonaEIntratracheal administration of influenza virus is superior to intranasal administration as a model of acute lung injuryJ Virol Methods201420911612025239366
   PubMed Web of Science ®Google Scholar
• JosephTMcAuliffeJLuBJinHKembleGSubbaraoKEvaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse modelJ Virol20078119105581056617634234
   PubMed Web of Science ®Google Scholar
• LuXTumpeyTMMorkenTZakiSRCoxNJKatzJMA mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humansJ Virol19997375903591110364342
   PubMed Web of Science ®Google Scholar
• MainesTRLuXHErbSMAvian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammalsJ Virol20057918117881180016140756
   PubMed Web of Science ®Google Scholar
• EatonMDTransmission of epidemic influenza virus in mice by contactJ Bacteriol194039322924116560287
   PubMedGoogle Scholar
• SchulmanJLExperimental transmission of influenza virus infection in mice. IV. Relationship of transmissibility of different strains of virus and recovery of airborne virus in the environment of infector miceJ Exp Med196712534794886016901
   PubMed Web of Science ®Google Scholar
• SchulmanJLKilbourneEDAirborne transmission of influenza virus infection in miceNature19621951129113013909471
   PubMed Web of Science ®Google Scholar
• SchulmanJLKilbourneEDExperimental transmission of influenza virus infection in mice. Ii. Some factors affecting the incidence of transmitted infectionJ Exp Med196311826727514074390
   PubMed Web of Science ®Google Scholar
• LowenACMubarekaSTumpeyTMGarcia-SastreAPalesePThe guinea pig as a transmission model for human influenza virusesProc Natl Acad Sci U S A2006103269988999216785447
   PubMed Web of Science ®Google Scholar
• von ItzsteinMWuWYKokGBRational design of potent sialidase-based inhibitors of influenza virus replicationNature199336364284184238502295
   PubMed Web of Science ®Google Scholar
• GovorkovaEALenevaIAGoloubevaOGBushKWebsterRGComparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza virusesAntimicrob Agents Chemother200145102723273211557461
   PubMed Web of Science ®Google Scholar
• SidwellRWSmeeDFHuffmanJHInfuence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201Antiviral Res200151317918711448729
   PubMed Web of Science ®Google Scholar
• DaviesWLGrunertRRHaffRFAntiviral activity of 1- adamantanamine (amantadine)Science1964144362086286314151624
   PubMed Web of Science ®Google Scholar
• RabinovichSRimantadine therapy of influenza A infection in miceAntimicrob Agents Chemother1972154084114670482
   PubMed Web of Science ®Google Scholar
• PanWDongZLiFVisualizing influenza virus infection in living miceNat Commun20134236924022374
   PubMed Web of Science ®Google Scholar
• RongvauxATakizawaHStrowigTHuman hemato-lymphoid system mice: current use and future potential for medicineAnnu Rev Immunol20133163567423330956
   PubMed Web of Science ®Google Scholar
• BrehmMAShultzLDGreinerDLHumanized mouse models to study human diseasesCurr Opin Endocrinol Diabetes Obes201017212012520150806
   PubMedGoogle Scholar
• AkkinaRNew generation humanized mice for virus research: comparative aspects and future prospectsVirology20134351142823217612
   PubMed Web of Science ®Google Scholar
• ItoRTakahashiTKatanoIItoMCurrent advances in humanized mouse modelsCell Mol Immunol20129320821422327211
   PubMed Web of Science ®Google Scholar
• WillingerTRongvauxATakizawaHHuman IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lungProc Natl Acad Sci U S A201110862390239521262803
   PubMed Web of Science ®Google Scholar
• RongvauxAWillingerTMartinekJDevelopment and function of human innate immune cells in a humanized mouse modelNat Biotechnol201432436437224633240
   PubMed Web of Science ®Google Scholar